Literature DB >> 1569096

Mechanism of assembly of the RNA polymerase II preinitiation complex. Evidence for a functional interaction between the carboxyl-terminal domain of the largest subunit of RNA polymerase II and a high molecular mass form of the TATA factor.

R C Conaway1, J N Bradsher, J W Conaway.   

Abstract

Genetic evidence argues that the highly conserved carboxyl-terminal domain (CTD) of the largest subunit of RNA polymerase II functions directly in the regulation of transcription of many eukaryotic genes. The observation that partial deletion of the CTD of yeast RNA polymerase II reduces the ability of the enzyme to respond to signals from a variety of upstream activating sequences led to the proposal that the CTD plays a role in the dialogue between regulatory factors that bind upstream activating sequences and the "general" or "basal" transcription factors associated with RNA polymerase II at the promoter (Scafe, C., Chao, D., Lopes, J., Hirsch, J. P., Henry, S., and Young, R. A. (1990) Nature 347, 491-494). Biochemical evidence for an interaction of the CTD with specific components of the basal transcription apparatus, however, has been lacking. To identify target(s) for CTD action, we probed steps in assembly of the RNA polymerase II preinitiation complex with monoclonal antibodies specific for the CTD. Our findings reveal a novel interaction of the CTD with a high molecular mass form of the TATA factor. This interaction occurs during binding of RNA polymerase II to its promoter and requires the action of additional basal transcription factors; it is not observed when the single-subunit yeast transcription factor IID serves as the TATA factor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569096

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Analysis of the requirement for RNA polymerase II CTD heptapeptide repeats in pre-mRNA splicing and 3'-end cleavage.

Authors:  Emanuel Rosonina; Benjamin J Blencowe
Journal:  RNA       Date:  2004-04       Impact factor: 4.942

Review 2.  RNA polymerase II C-terminal domain: Tethering transcription to transcript and template.

Authors:  Jeffry L Corden
Journal:  Chem Rev       Date:  2013-09-16       Impact factor: 60.622

3.  RNA polymerase II is aberrantly phosphorylated and localized to viral replication compartments following herpes simplex virus infection.

Authors:  S A Rice; M C Long; V Lam; C A Spencer
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

4.  The identification of putative RNA polymerase II C-terminal domain associated proteins in red and green algae.

Authors:  Chunlin Yang; Paul W Hager; John W Stiller
Journal:  Transcription       Date:  2014-12-10

5.  The C-terminal domain of Saccharomyces cerevisiae DNA topoisomerase II.

Authors:  P R Caron; P Watt; J C Wang
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

6.  Nuclear factor I and mammary gland factor (STAT5) play a critical role in regulating rat whey acidic protein gene expression in transgenic mice.

Authors:  S Li; J M Rosen
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

Review 7.  Dephosphorylating eukaryotic RNA polymerase II.

Authors:  Joshua E Mayfield; Nathaniel T Burkholder; Yan Jessie Zhang
Journal:  Biochim Biophys Acta       Date:  2016-01-15

8.  A highly conserved domain of RNA polymerase II shares a functional element with acidic activation domains of upstream transcription factors.

Authors:  H Xiao; J D Friesen; J T Lis
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

9.  The upstream activator CTF/NF1 and RNA polymerase II share a common element involved in transcriptional activation.

Authors:  H Xiao; J T Lis; H Xiao; J Greenblatt; J D Friesen
Journal:  Nucleic Acids Res       Date:  1994-06-11       Impact factor: 16.971

10.  Functional studies of the carboxy-terminal repeat domain of Drosophila RNA polymerase II in vivo.

Authors:  W J Brickey; A L Greenleaf
Journal:  Genetics       Date:  1995-06       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.